Caspofungin for the treatment of invasive fungal disease in hematological patients (ProCAS Study)

References

• Denning DW. Echinocandins: a new class of antifungal. J Antimicrob Chemother 2002; 49: 889–891.
   PubMed Web of Science ®Google Scholar
• Wagner C, Graninger W, Presterl E, Joukhadar C. The echinocandins: comparison of their pharmacokinetics, pharmacodynamics and clinical applications. Pharmacology 2006; 78: 161–177.
   PubMed Web of Science ®Google Scholar
• Mora-Duarte J, Betts R, Rotstein C, . Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 2002; 347: 2020–2029.
   PubMed Web of Science ®Google Scholar
• Cornely O, Lasso M, Betts R, . Caspofungin for the treatment of less common forms of invasive candidiasis. J Antimicrob Chemother 2007; 60: 363–369.
   PubMed Web of Science ®Google Scholar
• Maertens J, Raad I, Petrikkos G, . Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin Infect Dis 2004; 39: 1563–1571.
   PubMed Web of Science ®Google Scholar
• Ascioglu S, Rex JH, De Paux B, . Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7–14.
   PubMed Web of Science ®Google Scholar
• Sipsas NV, Lewis RE, Raad II, Kontoyiannis DP. Monotherapy with caspofungin for candidaemia in adult patients with cancer: a retrospective, single institution study. Int J Antimicrob Agents 2009; 34: 95–98.
   Google Scholar
• Pagano L, Fianchi L, Fanci R, . Caspofungin for the treatment of candidaemia in patients with haematological malignancies. Clin Microbiol Infect 2010; 16: 298–301.
   Google Scholar
• Cantón E, Espinel-Ingroff A, Pemán J, del Castillo L. In vitro fungicidal activities of echinocandins against Candida metapsilosis, C. orthopsilosis, and C. parapsilosis evaluated by time-kill studies. Antimicrob Agents Chemother 2010; 54: 2194–2197.
   PubMedGoogle Scholar
• Hachem R, Hanna H, Kontoyiannis D, Jiang Y, Raad I. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy. Cancer 2008; 112: 2493–2499.
   PubMed Web of Science ®Google Scholar
• Horn DL, Neofytos D, Anaissie EJ, . Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 2009; 48: 1695–1703.
   PubMed Web of Science ®Google Scholar
• Conen A, Weisser M, Jörg CO, . Candida krusei ‐ a serious complication in patients with hematological malignancies: successful treatment with caspofungin. Transpl Infect Dis 2008; 10: 66–70.
   Google Scholar
• Fanci R, Guidi S, Bonolis M, Bosi A. Candida krusei fungemia in an unrelated allogeneic hematopoietic stem cell transplant patient successfully treated with caspofungin. Bone Marrow Transplant 2005; 35: 1215–1216.
   Google Scholar
• McGee WT, Tereso GJ. Successful treatment of Candida krusei infection with caspofungin acetate: a new antifungal agent. Crit Care Med 2003; 31: 1577–1578.
   PubMed Web of Science ®Google Scholar
• Schilling A, Seibold M, Mansmann V, Gleissner B. Successfully treated Candida krusei infection of the lumbar spine with combined caspofungin/posaconazole therapy. Med Mycol 2008; 46: 79–83.
   PubMed Web of Science ®Google Scholar
• Pemán J, Jarque I, Bosch M, . Spondylodiscitis caused by Candida krusei: case report and susceptibility patterns. J Clin Microbiol 2006; 44: 1912–1914.
   PubMed Web of Science ®Google Scholar
• Maertens J, Glasmacher A, Herbrecht R, . Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis. Cancer 2006; 107:2888–2897.
   PubMed Web of Science ®Google Scholar
• Glasmacher A, Cornely OA, Orlopp K, . Caspofungin treatment in severely ill, immunocompromised patients: a case- documentation study of 118 patients. J Antimicrob Chemother 2006; 57: 127–134.
   PubMed Web of Science ®Google Scholar
• Chamilos G, Luna M, Lewis RE, . Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989–2003). Haematologica 2006; 91: 986–989.
   PubMed Web of Science ®Google Scholar
• Wheat LJ, Walsh TJ. Diagnosis of invasive aspergillosis by galactomannan antigenemia detection using an enzyme immunoassay. Eur J Clin Microbiol Infect Dis 2008; 27: 245–251.
   PubMed Web of Science ®Google Scholar